title: The use of psychotropic medication during pregnancy: how about the newborn?
abstract: Infants are at risk of developing symptoms of Poor Neonatal Adaptation (PNA) after exposure to psychotropic drugs in utero. Such symptoms are largely similar after exposure to antidepressants, antipsychotics and benzodiazepines and consist of mostly mild neurologic, autonomic, respirator and gastro-intestinal abnormalities. Most symptoms develop within 48 hours after birth and last for 2-6 days. After exposure to Selective Serotonin Reuptake Inhibitors (SSRIs), mirtazapine or venlafaxine in utero, breastfeeding is presumably protective for development of PNA. The dosage of antidepressants does not seem to be related to the risk of PNA. In order to objectify possible symptoms of PNA, observation of mother and child at the maternity ward is advisable. If PNA symptoms do not occur, an observation period of 48-72 hours is sufficient. This applies to all types of psychotropic drugs. When PNA symptoms are present it is advisable to observe the infant until the symptoms are fully resolved. Observation can be performed by trained nurses using the Finnegan scoring list. This observation list should be administered every 8 hours. Interpretation of the scores should be carried out by a paediatrician. In most cases symptoms are non-specific. Therefore other diagnoses, such as infection or neurologic problems, have to be excluded. When there is any doubt on possible intoxications during pregnancy, toxicological urine screening is indicated. Most cases of PNA are mild, of short duration and self-limiting without need for treatment. Supporting measures such as frequent small feedings, swaddling and increase of skin to skin contact with the mother is usually sufficient. In case of severe PNA it is advised to admit the infant to the Neonatal Care Unit (NCU). Phenobarbital is a safe therapeutic option. There seem to be no major long term effects; however, additional studies are necessary in order to draw definite conclusions.
authors.affiliation: Department of Paediatrics, Amsterdam, The Netherlands.
authors.forename: Noera
authors.initials: N
authors.lastname: Kieviet
authors.forename: Koert M
authors.initials: KM
authors.lastname: Dolman
authors.forename: Adriaan
authors.initials: A
authors.lastname: Honig
keywords: SSRI; antidepressants; neonatal abstinence; psychiatric disorders; withdrawal
references.citation: N Engl J Med. 2011 Oct 27;365(17):1605-11
references.pmid: 22029982
references.citation: Drug Saf. 2005;28(2):137-52
references.pmid: 15691224
references.citation: Arch Dis Child Fetal Neonatal Ed. 2006 Mar;91(2):F153
references.pmid: 16492956
references.citation: Int J Clin Pharmacol Biopharm. 1975 Jul;12(1-2):19-32
references.pmid: 1100537
references.citation: Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):801-6
references.pmid: 18314924
references.citation: Arch Dis Child Fetal Neonatal Ed. 2012 Nov;97(6):F472-6
references.pmid: 23080479
references.citation: Acta Paediatr. 2010 Apr;99(4):497-501
references.pmid: 20055774
references.citation: JAMA. 2005 May 18;293(19):2372-83
references.pmid: 15900008
references.citation: Obstet Gynecol Surv. 2008 Apr;63(4):267-79
references.pmid: 18348740
references.citation: Lancet. 2005 Feb 5-11;365(9458):482-7
references.pmid: 15705457
references.citation: Curr Opin Pediatr. 2012 Apr;24(2):252-8
references.pmid: 22227786
references.citation: Infant Behav Dev. 2010 Dec;33(4):409-18
references.pmid: 20471091
references.citation: CMAJ. 2005 May 24;172(11):1457-9
references.pmid: 15911861
references.citation: Arch Pediatr Adolesc Med. 2006 Feb;160(2):173-6
references.pmid: 16461873
references.citation: Child Dev. 1996 Oct;67(5):2512-26
references.pmid: 9022253
references.citation: Aust N Z J Psychiatry. 2009 Sep;43(9):846-54
references.pmid: 19670058
references.citation: J Clin Psychopharmacol. 2008 Jun;28(3):334-9
references.pmid: 18480693
references.citation: J Obstet Gynaecol Can. 2006 Apr;28(4):299-301
references.pmid: 16776907
references.citation: Am J Med Genet A. 2005 Feb 1;132A(4):441-4
references.pmid: 15633173
references.citation: J Dev Behav Pediatr. 1990 Aug;11(4):190-4
references.pmid: 2212032
references.citation: Pharmacoepidemiol Drug Saf. 2002 Jun;11(4):281-3
references.pmid: 12138595
references.citation: Pharmacotherapy. 1993 May-Jun;13(3):202-11
references.pmid: 8321734
references.citation: CNS Spectr. 2010 Mar;15(3):167-85
references.pmid: 20414166
references.citation: BMC Health Serv Res. 2009 Jul 17;9:119
references.pmid: 19615056
references.citation: Acta Psychiatr Scand. 2013 Feb;127(2):94-114
references.pmid: 23240634
references.citation: Reprod Toxicol. 2012 Nov;34(3):293-7
references.pmid: 22564982
references.citation: Hum Psychopharmacol. 2007 Apr;22(3):121-8
references.pmid: 17397101
references.citation: Am J Psychiatry. 2007 Aug;164(8):1214-20
references.pmid: 17671284
references.citation: Am J Obstet Gynecol. 2003 Jul;189(1):148-54
references.pmid: 12861154
references.citation: Mol Psychiatry. 2008 Jan;13(1):65-73
references.pmid: 17519929
references.citation: J Pediatr. 2010 Sep;157(3):428-33, 433.e1
references.pmid: 20472252
references.citation: Br Med J (Clin Res Ed). 1981 Apr 4;282(6270):1106-8
references.pmid: 6113019
references.citation: Ned Tijdschr Geneeskd. 2010;154(8):A339
references.pmid: 21108858
references.citation: Isr J Psychiatry Relat Sci. 2008;45(2):107-13
references.pmid: 18982836
references.citation: J Clin Psychiatry. 2011 Jul;72(7):994-1001
references.pmid: 21824458
references.citation: Psychosom Med. 2010 Oct;72(8):769-76
references.pmid: 20668282
references.citation: Pharmacol Ther. 2012 Jul;135(1):71-7
references.pmid: 22483705
references.citation: Curr Opin Psychiatry. 2011 Jan;24(1):34-40
references.pmid: 21088587
references.citation: Arch Gen Psychiatry. 2006 Aug;63(8):898-906
references.pmid: 16894066
references.citation: Handb Exp Pharmacol. 2012;(214):279-305
references.pmid: 23027456
references.citation: CNS Drugs. 2009;23(6):493-509
references.pmid: 19480468
references.citation: Drug Saf. 2011 Nov 1;34(11):1027-48
references.pmid: 21981432
references.citation: Am J Psychiatry. 2005 Nov;162(11):2162-70
references.pmid: 16263858
references.citation: Ther Drug Monit. 2006 Feb;28(1):142-3; author reply 143
references.pmid: 16418711
references.citation: J Perinatol. 2011 Sep;31(9):615-20
references.pmid: 21311497
references.citation: J Affect Disord. 2010 Feb;121(1-2):100-5
references.pmid: 19501914
references.citation: Gen Hosp Psychiatry. 2009 Sep-Oct;31(5):403-13
references.pmid: 19703633
references.citation: Ther Drug Monit. 2006 Feb;28(1):5-7
references.pmid: 16418684
references.citation: J Clin Psychiatry. 2004 Feb;65(2):230-7
references.pmid: 15003078
references.citation: Pediatrics. 2004 Feb;113(2):368-75
references.pmid: 14754951
references.citation: Drug Saf. 2007;30(3):247-64
references.pmid: 17343431
references.citation: Int Pharmacopsychiatry. 1976;11(4):246-60
references.pmid: 13047
references.citation: Indian Pediatr. 2006 Jan;43(1):66-9
references.pmid: 16465011
references.citation: Br J Clin Pharmacol. 2012 Feb;73(2):295-302
references.pmid: 21801198
references.citation: J Womens Health (Larchmt). 2003 May;12(4):373-80
references.pmid: 12804344
references.citation: Nord J Psychiatry. 2012 Jun;66(3):159-66
references.pmid: 22283766
references.citation: Aust N Z J Psychiatry. 2010 Feb;44(2):99-108
references.pmid: 20113298
references.citation: Am J Psychiatry. 1996 May;153(5):592-606
references.pmid: 8615404
references.citation: N Engl J Med. 1996 Oct 3;335(14):1010-5
references.pmid: 8793924
references.citation: Expert Opin Drug Saf. 2012 May;11(3):425-37
references.pmid: 22400907
references.citation: Arch Pediatr Adolesc Med. 2002 Nov;156(11):1129-32
references.pmid: 12413342
references.citation: Curr Opin Obstet Gynecol. 2011 Dec;23(6):408-14
references.pmid: 21897237
references.citation: Ned Tijdschr Geneeskd. 2012;156(16):A4395
references.pmid: 22510415
references.citation: J Perinatol. 2005 Sep;25(9):595-604
references.pmid: 16015372
references.citation: Hum Psychopharmacol. 2012 Nov;27(6):534-9
references.pmid: 23044635
references.citation: Int J Neurosci. 2010 Mar;120(3):163-7
references.pmid: 20374082
references.citation: Acta Psychiatr Scand. 2010 Jun;121(6):471-9
references.pmid: 19878137
references.citation: Biol Res Pregnancy Perinatol. 1984;5(1):23-35
references.pmid: 6142732
references.citation: Adv Neonatal Care. 2011 Aug;11(4):282-90
references.pmid: 22123351
references.citation: Br J Clin Pharmacol. 2008 Apr;65(4):600-6
references.pmid: 17953715
references.citation: Arch Dis Child Fetal Neonatal Ed. 2001 Sep;85(2):F147-8
references.pmid: 11561552
references.citation: Pediatrics. 2012 Feb;129(2):e540-60
references.pmid: 22291123
references.citation: J Toxicol Clin Toxicol. 2001;39(4):381-92
references.pmid: 11527233
references.citation: Psychol Med. 2007 Apr;37(4):537-46
references.pmid: 17076915
references.citation: Can J Psychiatry. 1986 Apr;31(3):183-90
references.pmid: 2871917
references.citation: Aust N Z J Psychiatry. 2010 Nov;44(11):967-77
references.pmid: 21034180
references.citation: Aust N Z J Psychiatry. 2010 Nov;44(11):978-96
references.pmid: 21034181
references.citation: Hosp Community Psychiatry. 1985 Aug;36(8):817-8
references.pmid: 2863210
references.citation: Arch Bronconeumol. 2008 Oct;44(10):509-11
references.pmid: 19006629
references.citation: Pharmacopsychiatry. 2009 May;42(3):95-100
references.pmid: 19452377
references.citation: Br J Psychiatry. 2008 May;192(5):338-43
references.pmid: 18450656
references.citation: J Clin Psychopharmacol. 1989 Apr;9(2):78-87
references.pmid: 2656779
references.citation: Pediatrics. 2007 Jan;119(1):52-9
references.pmid: 17200271
references.citation: Obstet Gynecol Surv. 2011 Dec;66(12):777-87
references.pmid: 22192462
references.citation: Reprod Toxicol. 1994 Nov-Dec;8(6):461-75
references.pmid: 7881198
references.citation: J Hum Lact. 2010 May;26(2):187-95
references.pmid: 19652194
references.citation: Ther Drug Monit. 2009 Jun;31(3):404-9
references.pmid: 19455083
references.citation: N Engl J Med. 2006 May 18;354(20):2188-90; author reply 2188-90
references.pmid: 16707761
references.citation: Drug Saf. 2001;24(3):183-97
references.pmid: 11347722
references.citation: Arch Gen Psychiatry. 2003 Jul;60(7):720-6
references.pmid: 12860776
references.citation: Psychiatr Danub. 2010 Mar;22(1):90-3
references.pmid: 20305598
references.citation: Can J Psychiatry. 2004 Oct;49(10):684-9
references.pmid: 15560315
references.citation: Curr Med Chem. 2012;19(27):4554-61
references.pmid: 22876893
references.citation: J Child Psychol Psychiatry. 2008 Oct;49(10):1079-88
references.pmid: 19017024
references.citation: Ther Drug Monit. 2012 Dec;34(6):607-14
references.pmid: 23042258
references.citation: J Obstet Gynaecol Can. 2009 Apr;31(4):348-350
references.pmid: 19497154
references.citation: Arch Pediatr Adolesc Med. 2004 Apr;158(4):312-6
references.pmid: 15066868
references.citation: Psychol Med. 2006 Dec;36(12):1663-70
references.pmid: 16863595
references.citation: Pediatrics. 2006 Jun;117(6):e1163-9
references.pmid: 16740817